Babyscripts is a technology company.
Babyscripts has raised $8.0M across 1 funding round.
Babyscripts has raised $8.0M in total across 1 funding round.
Babyscripts has raised $8.0M in total across 1 funding round.
Babyscripts's investors include Acrew Capital, Amino Capital, Cathay Innovation, Clocktower Technology Ventures, DST Global, Forerunner Ventures, Homebrew, Inspired Capital, Menlo Ventures, Motivate Ventures, Outcast Ventures, PivotNorth Capital.
Babyscripts is a digital health company providing a comprehensive remote patient monitoring (RPM) and patient engagement platform for prenatal and postpartum maternity care. It builds tools like mobile apps (myJourney for education and self-care, myBloodPressure for RPM, myMentalHealth for screenings), IoT devices such as Bluetooth blood pressure cuffs, and provider dashboards to enable early risk detection for conditions like preeclampsia, gestational hypertension, mental health issues, and social determinants of health[1][3][5]. The platform serves health systems, hospitals, physicians, midwives, private practices, and payers, solving problems of limited access to care, high in-person visit burdens (reducing 12-14 visits via virtual tools), poor patient compliance, and late complication detection by offering scalable, billable RPM with 24/7 care management and EMR integrations (e.g., Epic, Cerner)[2][3][6][7]. Growth momentum includes over a decade of operation since 2014, partnerships like LCMC Health (detecting preeclampsia 2 weeks earlier, 4x more data, 30% higher engagement), alignment with ACOG guidelines and CMS reimbursements, and expansion from low-risk to high-risk patients pre-COVID[1][2].
Founded nearly a decade ago around 2014, Babyscripts pioneered RPM for pregnancy blood pressure monitoring, starting with low-risk patients to transform traditional prenatal schedules via IoT devices and digital companions[1][2][3]. The idea emerged from a vision to empower expectant mothers with self-monitoring tools for early intervention, reducing clinic visits while maintaining care quality; it expanded in 2019 to high-risk categories (normotensive, chronic/prenatal/postpartum hypertension) and postpartum care, anticipating ACOG and AIM guidelines[2]. Early traction came from clinical research-backed data, out-of-the-box solutions ready during COVID, and partnerships demonstrating superior outcomes, evolving into a full patient engagement platform with mental health and social assessments[1][2][4].
Babyscripts rides the maternal health tech wave, addressing U.S. maternal mortality crisis (rising complications like hypertension/mental health) amid trends in RPM reimbursement, virtual care post-COVID, and CMS's Transforming Maternal Health model promoting equity/access[1]. Timing aligns with regulatory tailwinds (e.g., payer RPM codes, ACOG postpartum guidance it preempted), enabling scalable growth for overburdened OB providers facing visit shortages[2][7]. Market forces like health system consolidation, payer risk stratification, and digital health ROI (e.g., ROI via visit reduction) favor it; Babyscripts influences the ecosystem by setting RPM standards, partnering nationwide, and mirroring comprehensive care shifts in competitors[1][2][8].
Babyscripts is poised for expansion as RPM adoption accelerates with CMS incentives and AI-enhanced monitoring; expect deeper EMR integrations, payer-scale deployments, and modules for emerging risks like climate-impacted pregnancies. Trends in value-based maternal care and mental health parity will amplify its data-driven model, potentially evolving influence via acquisitions or population health leadership—cementing its role from RPM pioneer to full maternity ecosystem enabler, much like its foundational shift from clinic-bound to virtual care[1][2].
Babyscripts has raised $8.0M across 1 funding round. Most recently, it raised $8.0M Series A in July 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2017 | $8.0M Series A | Acrew Capital, Amino Capital, Cathay Innovation, Clocktower Technology Ventures, DST Global, Forerunner Ventures, Homebrew, Inspired Capital, Menlo Ventures, Motivate Ventures, Outcast Ventures, PivotNorth Capital, Vitalize Venture Group, Kevin Colas, Sue Xu, Zander Lurie |